Here we go...shorters on the driver seat.
IPCI, bring on some news, it's unreal when you compare the stock performance to Others I'm watching...they double in weeks based on pII trials or some new analyst coverage.
We had approvals (2 Andas),
Analyst coverage (TP more than double than current),
competitors falling apart,
hot abuse deterrent sector (with politics and FDA all pushing)
very diversified pipeline (really unsual for such a small co)
...and we are back again below 2.5 ??
C'mon IPCI, it's time to push all the manipulators out !